DS
Elliasu Yakubu Salifu
Tshwane University of Technology, University of KwaZulu-Natal, University for Development Studies, South African Medical Research Council
Research areas: Pharmacology, Toxicology and Pharmaceutics · Drug Discovery · Computational Drug Discovery Methods · Protein Structure and Dynamics · Tuberculosis Research and Epidemiology
0000-0001-8713-5001
Employment
-
Tshwane University of Technology Postdoctoral Research Fellow2025 - Present
-
South African Medical Research Council Postdoctoral Research Fellow2023 - 2025
-
University of KwaZulu-Natal Postdoctoral Research Fellow
Education
-
University of KwaZulu-Natal PhD Pharmaceutical Chemistry2020 - 2023
-
University of KwaZulu-Natal MMedSc Pharmaceutical Chemistry2018 - 2019
-
University for Development Studies BSc Applied Biology2010 - 2014
Projects & Funding
Projects & funding information is unavailable.
Publications (29)
- The Antimycobacterial Activity, Toxicity and Chemical Composition of South African Propolis Save
- Zembrin® Mitigates Reserpine-Induced Motor Dysfunction and Oxidative Stress in Parkinson’s Disease: In Vivo and In Silico Analyses Save
- Identification of Enhanced Cyclooxygenase-2 (COX-2) Inhibitors Beyond Curcumin Through Virtual Screening to Target Inflammation-Related Metabolic Complications Save
- An integrated computational bioprospection of flavonoids as modulators of Mycobacterium tuberculosis decaprenylphosphoryl-β-d-ribose-2′-epimerase 1 Save
- Exploring the Effects of Chirality of 5-methyl-5-[4-(4-oxo-3H-quinazolin-2-yl)phenyl]imidazolidine-2,4-dione and its Derivatives on the Oncological Target Tankyrase 2. Atomistic Insights Save
- Evaluating the Therapeutic Potential of Curcumin and Synthetic Derivatives: A Computational Approach to Anti-Obesity Treatments Save
- Multi-functional pH-responsive and biomimetic chitosan-based nanoplexes for targeted delivery of ciprofloxacin against bacterial sepsis Save
- Unraveling the Dual Inhibitory Mechanism of Compound 22ac: A Molecular Dynamics Investigation into ERK1 and ERK5 Inhibition in Cancer Save
- In silico identification of potential inhibitors of acyl carrier protein reductase and acetyl CoA carboxylase of Plasmodium falciparum in antimalarial therapy Save
- Discovery of Potential KRAS-SOS1 Inhibitors from South African Natural Compounds: An In silico Approach Save
- Dual-Target Mycobacterium tuberculosis Inhibition: Insights into the Molecular Mechanism of Antifolate Drugs Save
- Halting aberrant DNA methylation via in silico Identification of potent inhibitors of DNMT3B enzyme: Atomistic insights Save
- The Unusual Architecture of RNA-Dependent RNA Polymerase (RdRp)’s Catalytic Chamber Provides a Potential Strategy for Combination Therapy against COVID-19 Save
- Molecular modelling of SdiA protein by selected flavonoid and terpenes compounds to attenuate virulence in Klebsiella pneumoniae Save
- Inside the cracked kernel: establishing the molecular basis of AMG510 and MRTX849 in destabilising KRASG12C mutant switch I and II in cancer treatment Save
- Impact of compound mutations I1171N + F1174I and I1171N + L1198H on the structure of ALK in NSCLC pathogenesis: atomistic insights Save
- Molecular Dynamic Investigation of H5N1 Influenza Virus Dual H274Y-I222K Mutation Resistance to Peramivir Save
- Prioritizing the Catalytic Gatekeepers through Pan- Inhibitory Mechanism of Entrectinib against ALK, ROS1 and TRKA Tyrosine Kinases Save
- Dual‐Inhibition of Human N ‐Myristoyltransferase Subtypes Halts Common Cold Pathogenesis: Atomistic Perspectives from the Case of IMP‐1088** Save
- Disrupting the characteristic twist motion; tailored in silico approach towards the design of plasmepsin inhibitors Save